These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2184544)

  • 1. Synergistic interaction of a protease and protease inhibitors from Russell's viper (Vipera russelli) venom.
    Jayanthi GP; Gowda TV
    Toxicon; 1990; 28(1):65-74. PubMed ID: 2184544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and partial biochemical characterization of an edema inducing phospholipase A2 from Vipera russelli (Russell's viper) snake venom.
    Vishwanath BS; Kini RM; Gowda TV
    Toxicon; 1988; 26(8):713-20. PubMed ID: 3188061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geographical variation in India in the composition and lethal potency of Russell's viper (Vipera russelli) venom.
    Jayanthi GP; Gowda TV
    Toxicon; 1988; 26(3):257-64. PubMed ID: 3293265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of catalytic activity and neurotoxicity of a basic phospholipase A2 from Russell's viper (Vipera russelli) venom.
    Jayanthi GP; Kasturi S; Gowda TV
    Toxicon; 1989; 27(8):875-85. PubMed ID: 2781586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative characterisation of Russell's viper (Daboia/Vipera russelli) venoms from different regions of the Indian peninsula.
    Prasad NB; Uma B; Bhatt SK; Gowda VT
    Biochim Biophys Acta; 1999 Aug; 1428(2-3):121-36. PubMed ID: 10434030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of a major phospholipase A2 from Russell's viper (Vipera russelli) venom.
    Kasturi S; Gowda TV
    Toxicon; 1989; 27(2):229-37. PubMed ID: 2718191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A major lethal factor of the venom of Burmese Russell's viper (Daboia russelli siamensis): isolation, N-terminal sequencing and biological activities of daboiatoxin.
    Maung-Maung-Thwin ; Gopalakrishnakone P; Yuen R; Tan CH
    Toxicon; 1995 Jan; 33(1):63-76. PubMed ID: 7778130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification, characterization and biological activities of phospholipase A from Russell's viper (Vipera russelli) venom.
    Aye-Kyaw ; San-Aye ; Tin-Win ; Hla-Pe ; Mya-Maung
    Int J Biochem; 1994 Jan; 26(1):79-83. PubMed ID: 8138052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of an organ specific haemorrhagic toxin from Vipera russelli russelli (Russell's viper) venom.
    Kole L; Chakrabarty D; Datta K; Bhattacharyya D
    Indian J Biochem Biophys; 2000 Apr; 37(2):114-20. PubMed ID: 10983422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between the venoms of two sub-species of Russell's viper: Vipera russelli pulchella and Vipera russelli siamensis.
    Woodhams BJ; Wilson SE; Xin BC; Hutton RA
    Toxicon; 1990; 28(4):427-33. PubMed ID: 2349584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A platelet aggregation inhibitor phospholipase A2 from Russell's viper (Vipera russelli) venom: isolation and characterization.
    Prasad BN; Kemparaju K; Bhatt KG; Gowda TV
    Toxicon; 1996 Oct; 34(10):1173-85. PubMed ID: 8931258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Snake venom proteinase inhibitors. II. Chemical structure of inhibitor II isolated from the venom of Russell's viper (Vipera russelli).
    Takahashi H; Iwanaga S; Kitagawa T; Hokama Y; Suzuki T
    J Biochem; 1974 Oct; 76(4):721-33. PubMed ID: 4436285
    [No Abstract]   [Full Text] [Related]  

  • 13. Factor X activating enzyme from Russell's viper venom: isolation and characterization.
    Kisiel W; Hermodson MA; Davie EW
    Biochemistry; 1976 Nov; 15(22):4901-6. PubMed ID: 990251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and partial characterization of a haemorrhagin (VRH-1) from Vipera russelli russelli venom.
    Chakrabarty D; Bhattacharyya D; Sarkar HS; Lahiri SC
    Toxicon; 1993 Dec; 31(12):1601-14. PubMed ID: 8146873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cation binding properties of the multiple subforms of RVV-X, the coagulant protein from Vipera russelli.
    Amphlett GW; Byrne R; Castellino FJ
    Biochemistry; 1982 Jan; 21(1):125-32. PubMed ID: 6800403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism of lung hemorrhage induction by VRV-PL-VIIIa from Russell's viper (Vipera russelli) venom.
    Uma B; Veerabasappa Gowda T
    Toxicon; 2000 Aug; 38(8):1129-47. PubMed ID: 10708803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Snake venom proteinase inhibitors. I. Isolation and properties of two inhibitors of kallikrein, trypsin, plasmin, and alpha-chymotrypsin from the venom of Russell's viper (Vipera russelli).
    Takahashi H; Iwanaga S; Suzuki T
    J Biochem; 1974 Oct; 76(4):709-19. PubMed ID: 4279913
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of a novel pro-coagulant metalloprotease (RVBCMP) possessing alpha-fibrinogenase and tissue haemorrhagic activity from venom of Daboia russelli russelli (Russell's viper): evidence of distinct coagulant and haemorrhagic sites in RVBCMP.
    Mukherjee AK
    Toxicon; 2008 Apr; 51(5):923-33. PubMed ID: 18249434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A platelet function inhibitor purified from Vipera russelli siamensis (Smith) snake venom.
    Li YS; Liu KF; Wang QC; Ran YL; Tu GC
    Toxicon; 1985; 23(6):895-903. PubMed ID: 4095704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on pharmacological effects of Russell's viper and Saw-scaled viper venom and its neutralization by chicken egg yolk antibodies.
    Meenatchisundaram S; Parameswari G; Michael A; Ramalingam S
    Int Immunopharmacol; 2008 Aug; 8(8):1067-73. PubMed ID: 18550009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.